HYPR
$1.30
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.
Recent News
Hyperfine Inc (HYPR) Q4 2025: Everything You Need To Know Ahead Of Earnings
This article first appeared on GuruFocus. Hyperfine Inc (NASDAQ:HYPR) is set to release its Q4 2025 earnings on March 18, 2026. The consensus estimate for Q4 2025 revenue is $5.16 million, and the earnings are expected to come in at -$0.08 per share.
Investors in Hyperfine (NASDAQ:HYPR) have unfortunately lost 87% over the last five years
Hyperfine, Inc. ( NASDAQ:HYPR ) shareholders should be happy to see the share price up 19% in the last month. But that...
Hyperfine Inc (HYPR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Hyperfine Inc (HYPR) reports a 27% revenue increase and unveils new technologies, despite facing international expansion challenges.
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Hyperfine (HYPR) delivered earnings and revenue surprises of -10.00% and +1.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Hyperfine (HYPR) Q3 2025 Earnings Call Transcript
Earlier today, Hyperfine, Inc. released financial results for the quarter ended September 30, 2025. Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained on this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements.